Individuals with Fontan circulation are at risk of late mortality from both cardiac and noncardiac causes. Despite the known risk of mortality, referral indications for advanced heart failure care vary […]
ACTION Learning Network investigators recently published Ventricular Assist Device Outcomes in Infants and Children With Stage 1 Single Ventricle Palliation in the November 2022 issue of the ASAIO Journal. Examining
“Outcomes After Initial Heart Failure Consultation in Fontan Patients” SHARON CHEN, ET AL. Download the Abstract
Patients with Fontan physiology may develop symptoms that require life-saving cardiac care such heart failure medicines, VAD support and/or transplantation. ACTION is working on timely referral for this cohort which is extremely important for optimal outcomes.
Fontan Referral for Advanced Care Read More »
Adult and pediatric surgery patients may develop signs and symptoms of heart failure or other organ diseases due to their Fontan circulation. These patients may need treatment such as cardiac medicines, mechanical devices, or transplantation.
Fontan Circulatory Failure Read More »
“Contemporary provider management practices and attitudes towards referral for advanced heart failure therapies in Fontan patients across North America” aimed to understand practice variations among Fontan caregivers, referral for advanced
Routine physical activity has been increasingly regarded as important for youth with cardiomyopathies or congenital heart disease with heart failure, including Fontan circulatory failure. This ACTION publication shows results of
Fontan patients are at risk for developing significant heart failure. This retrospective study investigates the efficacy of VAD support in 45 Fontan patients—the first Fontan multi-center cohort from ACTION centers:
Systemic VAD Support in Fontan Patients: A Report by ACTION Read More »
